Drug Trial Radar · NCT04341116
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
Last checked: Nov 19, 2026Latest source record: May 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
149
Actual
Start
Apr 11, 2020
Primary completion
Feb 7, 2022
Study completion Feb 7, 2022
Sponsor
- Lead sponsor
- I-Mab Biopharma US LimitedIndustry
- Sponsor type
- Industry
- First posted
- Apr 10, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multi-center trial to evaluate the safety and efficacy of TJ003234 administered as an intravenous (IV) infusion in subjects with severe COVID-19 under supportive care, and to assess the effect of TJ003234 on the levels of cytokines.
Conditions
- Coronavirus Disease 2019 COVID-19
Interventions
TJ003234Drug
patients receive a single infusion
PlaceboDrug
patients receive a single infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Alive and Free of Mechanical Ventilation Among Subjects Who Are Free of Mechanical Ventilation at BaselineTime frame: Day 1 through Day 30
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas
Little Rock, Arkansas
Olive View-UCLA Medical Center
Sylmar, California
Georgetown University Hospital
Washington D.C., District of Columbia
The GW Medical Faculty Associates
Washington D.C., District of Columbia
University of Miami
Miami, Florida
OSF Healthcare Saint Francis Medical Center
Peoria, Illinois
Indiana University Health
Indianapolis, Indiana
Medpharmics, LLC
Metairie, Louisiana
Ochsner Medical Center
New Orleans, Louisiana
Brigham and Women's Hospital
Boston, Massachusetts
University of Mississippi Medical Center
Jackson, Mississippi
University Medical Center of Southern Nevada
Las Vegas, Nevada
UNM Hospitals
Albuquerque, New Mexico
Houston Methodist Hospital
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.